FDA Peptide Reclassification 2026: What It Means for Providers Tirzepatide America's Top Manufacturing Facilities FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA considers adding a dozen peptides to its bulk drug compounding list RAPS